{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:10:48Z","timestamp":1791544248778,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deanship of Scientific Research at King Saud University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbr.2019.02.031","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T01:49:41Z","timestamp":1550540981000},"page":"213-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf\/J mice"],"prefix":"10.1016","volume":"364","author":[{"given":"Ahmed","family":"Nadeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh F.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naif O.","family":"Al-Harbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabry M","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A","family":"Bakheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid E.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faleh","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alqinyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.02.031_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders. Autism Spectrum Disorder","author":"APA","year":"2013"},{"key":"10.1016\/j.bbr.2019.02.031_bib0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/WCO.0b013e32835ee548","article-title":"Sex differences in autism spectrum disorders","volume":"26","author":"Werling","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0015","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S003329171400172X","article-title":"The epidemiology and global burden of autism spectrum disorders","volume":"45","author":"Baxter","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbr.2019.02.031_bib0020","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s10803-010-1171-z","article-title":"Brief report:\u201d allergic symptoms\u201d in children with autism spectrum disorders. More than meets the eye?","volume":"41","author":"Angelidou","year":"2011","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.bbr.2019.02.031_bib0025","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s10803-013-1973-x","article-title":"Gastrointestinal problems in children with autism, developmental delays or typical development","volume":"44","author":"Chaidez","year":"2014","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.bbr.2019.02.031_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fpubh.2013.00031","article-title":"A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel","volume":"1","author":"Frye","year":"2013","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bbr.2019.02.031_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pnpbp.2018.09.012","article-title":"Increased oxidative stress in the cerebellum and peripheral immune cells leads to exaggerated autism-like repetitive behavior due to deficiency of antioxidant response in BTBR T+tf\/j mice","volume":"89","author":"Nadeem","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.02.031_bib0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbi.2017.09.010","article-title":"Activation of IL-17 receptor leads to increased oxidative inflammation in peripheral monocytes of autistic children","volume":"67","author":"Nadeem","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2019.02.031_bib0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pnpbp.2018.08.020","article-title":"Dysregulated enzymatic antioxidant network in peripheral neutrophils and monocytes in children with autism","volume":"88","author":"Nadeem","year":"2019","journal-title":"Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.02.031_bib0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","article-title":"A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.02.031_bib0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1742-2094-9-158","article-title":"Elevated serum levels of interleukin-17A in children with autism","volume":"9","author":"Al-Ayadhi","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbr.2019.02.031_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pnpbp.2017.12.015","article-title":"Systemic inflammation in a social BTBR T+tf\/j mice predisposes them to increased psoriatic inflammation","volume":"83","author":"Nadeem","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.02.031_bib0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2015.07.003","article-title":"Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma","volume":"286","author":"Akintunde","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0070","doi-asserted-by":"crossref","first-page":"e5324","DOI":"10.1371\/journal.pone.0005324","article-title":"Gene-network analysis identifies susceptibility genes related to glycobiology in autism","volume":"4","author":"van der Zwaag","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2019.02.031_bib0075","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The maternal interleukin-17a pathway in mice promotes autism- like phenotypes in offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbr.2019.02.031_bib0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.expneurol.2017.04.010","article-title":"Maternal IL-17a in autism","volume":"299","author":"Wong","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0085","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1007\/s12035-016-9977-0","article-title":"Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism","volume":"54","author":"Ahmad","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"52","key":"10.1016\/j.bbr.2019.02.031_bib0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cellsig.2018.09.006","article-title":"S3I-201, a selective STAT3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T+ Itpr3tf\/J mice","volume":"2018","author":"Ahmad","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbr.2019.02.031_bib0095","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1007\/s12035-016-0066-1","article-title":"Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription factor Signaling in a BTBR T + tf\/J Mouse Model of Autism","volume":"54","author":"Bakheet","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0100","first-page":"47","volume":"vol.1","author":"Chauhan","year":"2010"},{"key":"10.1016\/j.bbr.2019.02.031_bib0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12011-010-8840-9","article-title":"Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation","volume":"143","author":"Meguid","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.bbr.2019.02.031_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019299","article-title":"In Search of Cellular Immunophenotypes in the Blood of Children with Autism","volume":"6","author":"Ashwood","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2019.02.031_bib0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000398791","article-title":"Role of microglia in autism: recent advances","volume":"37","author":"Takano","year":"2015","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.bbr.2019.02.031_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2017.05.018","article-title":"IL-17A causes depression-like symptoms via NF\u03baB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression","volume":"97","author":"Nadeem","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.bbr.2019.02.031_bib0125","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.freeradbiomed.2013.07.021","article-title":"Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes","volume":"65","author":"Gu","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbr.2019.02.031_bib0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nbd.2013.01.006","article-title":"Mitochondrial abnormalities in temporal lobe of autistic brain","volume":"54","author":"Tang","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2019.02.031_bib0135","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2:INrf2(Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbr.2019.02.031_bib0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cotox.2016.09.004","article-title":"NRF2 in neurodegenerative diseases","volume":"1","author":"Cuadrado","year":"2016","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0145","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2019.02.031_bib0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/srep00201","article-title":"Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis","volume":"1","author":"Pareek","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2019.02.031_bib0155","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7857186","article-title":"Coombes. Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician\u2019s expectation be matched by the reality?","volume":"2016","author":"Houghton","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbr.2019.02.031_bib0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3892\/ijmm.2015.2396","article-title":"Sulforaphane exerts anti-inflammatory effects against lipopolysaccharide-induced acute lung injury in mice through the Nrf2\/ARE pathway","volume":"37","author":"Qi","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbr.2019.02.031_bib0165","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.1300556","article-title":"Sulforaphane protects from T cell\u2013mediated autoimmune disease by inhibition of IL-23 and IL-12 in dendritic cells","volume":"192","author":"Geisel","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0170","doi-asserted-by":"crossref","DOI":"10.1177\/2164957X17735826","article-title":"Sulforaphane from broccoli reduces symptoms of autism: a follow-up case series from a randomized double-blind study","volume":"6","author":"Lynch","year":"2017","journal-title":"Glob. Adv. Health Med."},{"key":"10.1016\/j.bbr.2019.02.031_bib0175","doi-asserted-by":"crossref","first-page":"15550","DOI":"10.1073\/pnas.1416940111","article-title":"Sulforaphane treatment of autism spectrum disorder (ASD)","volume":"111","author":"Singh","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2019.02.031_bib0180","doi-asserted-by":"crossref","first-page":"14851","DOI":"10.1073\/pnas.1009926107","article-title":"NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain","volume":"107","author":"Kim","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2019.02.031_bib0185","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/npp.2015.66","article-title":"GABAB receptor agonist R-Baclofen reverses social deficits and reduces repetitive behavior in two mouse models of autism","volume":"40","author":"Silverman","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2019.02.031_bib0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.108.137208","article-title":"Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice","volume":"326","author":"Masood","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2019.02.031_bib0195","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrn2851","article-title":"Behavioural phenotyping assays for mouse models of autism","volume":"11","author":"Silverman","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbr.2019.02.031_bib0200","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1523\/JNEUROSCI.2010-17.2017","article-title":"Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypesin Mice","volume":"38","author":"Steinmetz","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2019.02.031_bib0205","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bbr.2019.02.031_bib0210","series-title":"Effect Size and Eta Squared","author":"Brown","year":"2008"},{"key":"10.1016\/j.bbr.2019.02.031_bib0215","series-title":"Calculation of Effect Sizes","author":"Lenhard","year":"2016"},{"issue":"66","key":"10.1016\/j.bbr.2019.02.031_bib0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.yrtph.2013.04.005","article-title":"Nrf2\/ARE is the potential pathway to protect sprague-dawley rats against oxidative stress induced by quinocetone","volume":"2013","author":"Yu","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"June(6)","key":"10.1016\/j.bbr.2019.02.031_bib0225","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbr.2019.02.031_bib0230","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1871527316666170102120211","article-title":"Preventive and protective roles of dietary Nrf2 activators against central nervous system diseases","volume":"16","author":"Sun","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.bbr.2019.02.031_bib0235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington\u2019s disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbr.2019.02.031_bib0240","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1568007054038238","article-title":"The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders","volume":"4","author":"van Muiswinkel","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"issue":"October(9)","key":"10.1016\/j.bbr.2019.02.031_bib0245","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fphar.2018.01182","article-title":"Essential role of Keap1-Nrf2 signaling in mood disorders: overview and future perspective","volume":"16","author":"Hashimoto","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0250","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","article-title":"Molecular basis of the Keap1-Nrf2 system","volume":"88","author":"Suzuki","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbr.2019.02.031_bib0255","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.etp.2010.11.005","article-title":"Protective effect of sulforaphane against oxidative stress: recent advances","volume":"64","author":"Guerrero-Beltr\u00e1n","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exger.2015.11.004","article-title":"Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice","volume":"73","author":"Townsend","year":"2016","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062189","article-title":"The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex","volume":"8","author":"McTighe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2019.02.031_bib0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fpsyt.2015.00121","article-title":"The impact of neuroimmune alterations in autism spectrum disorder","volume":"6","author":"Gottfried","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2019.02.031_bib0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.imlet.2014.11.006","article-title":"Evidence supporting an altered immune response in asd","volume":"163","author":"Mead","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbr.2019.02.031_bib0280","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/aur.42","article-title":"Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms","volume":"1","author":"Heuer","year":"2008","journal-title":"Autism Res."},{"key":"10.1016\/j.bbr.2019.02.031_bib0285","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.expneurol.2013.10.002","article-title":"Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice","volume":"250","author":"Li","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0290","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","article-title":"A validated regulatory network for Th17 cell specification","volume":"151","author":"Ciofani","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2019.02.031_bib0295","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2009.08.012","article-title":"Flavonoids, a prenatal prophylaxis via targeting JAK2\/STAT3 signaling to oppose IL-6\/MIA associated autism","volume":"217","author":"Parker-Athill","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0300","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1139\/cjpp-2015-0150","article-title":"Inhibition of STAT3 phosphorylation by sulforaphane reduces adhesion molecule expression in vascular endothelial cell","volume":"94","author":"Cho","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbr.2019.02.031_bib0305","doi-asserted-by":"crossref","first-page":"38619","DOI":"10.1038\/srep38619","article-title":"Nuclear Factor Erythroid 2-related Factor 2 Deficiency Exacerbates Lupus Nephritis in B6\/lpr mice by Regulating Th17 Cell Function","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbr.2019.02.031_bib0310","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55782\/ane-2012-1887","article-title":"Evidence of parallels between mercury intoxication and the brain pathology in autism","volume":"72","author":"Kern","year":"2012","journal-title":"Acta Neurobiol. Exp. (Wars.)"},{"key":"10.1016\/j.bbr.2019.02.031_bib0315","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbr.2019.02.031_bib0320","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.bbadis.2011.08.012","article-title":"Brain aging, Alzheimer\u2019s disease, and mitochondria","volume":"1812","author":"Swerdlow","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbr.2019.02.031_bib0325","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bcp.2008.07.036","article-title":"Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway","volume":"76","author":"Lin","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"February","key":"10.1016\/j.bbr.2019.02.031_bib0330","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ki.2013.343","article-title":"Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-\u03baB-mediated inflammatory response","volume":"85","author":"Jiang","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbr.2019.02.031_bib0335","article-title":"SkQ1 regulates expression of Nrf2, ARE-controlled genes encoding antioxidant enzymes, and their activity in cerebral cortex under oxidative stress","author":"Vnukov","year":"2017","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bbr.2019.02.031_bib0340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12012-008-9020-4","article-title":"Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress","volume":"8","author":"Zhu","year":"2008","journal-title":"Cardiovasc. Toxicol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818316358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818316358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T21:54:24Z","timestamp":1720994064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432818316358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":68,"alternative-id":["S0166432818316358"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.02.031","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf\/J mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}